Boiron

Société pharmaceutique6 produits suivis

produits suivis

85 055

total des notifications

rappels enregistrés

81,3%

graves au total

Produits

affichage de 6 sur 6

Produit	Approuvé	Notifications ↓	Signal principal	Rappels
ferrous sulfate —	1946	48 897	Maladie rénale chronique	10
senna leaf —	—	22 469	Immunodéficience	0
quinine —	2005	8 945	Abus de drogues	2
milk thistle —	—	4 170	problème de substitution de produit	0
cupric oxide —	—	572	Flatulence vaginale	0
avobenzone 3%, homosalate 13%, octisalate 5%, octocrylene 10%, oxybenzone 6% —	—	2	—	0

Historique des rappels · 12 enregistrés

Date	Classe	Motif	Fabricant
17 févr. 2025	II	Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.	Safecor Health, LLC
26 avr. 2023	II	CGMP Deviations: Firm went out of business and could no longer continue stability studies.	Akorn, Inc.
15 mars 2021	II	CGMP Deviations: Intermittent exposure to temperature excursion during storage.	Cardinal Health Inc.
31 mai 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
31 mai 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
7 mai 2018	II	CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.	RIJ Pharmaceutical LLC
10 avr. 2018	III	Presence of Foreign Tablets/Capsules	Aidarex Pharmaceuticals LLC
25 mars 2016	II	Lack of Processing Controls	Reliable Rexall-A Compounding Pharmacy
14 nov. 2014	II	Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.	Attix Pharmaceuticals
2 juil. 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD54549_16, EXP: 5/20/2014.	Aidapak Services, LLC
2 juil. 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W002711, EXP: 6/6/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W002825, EXP: 12/31/2013; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60236_1, EXP: 5/22/2014.	Aidapak Services, LLC
28 déc. 2012	I	Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness)	Advance Pharmaceutical Inc

Classe I = probabilité raisonnable de préjudice grave · Classe II = temporaire ou réversible · Classe III = peu susceptible de causer un préjudice.

Statut d'enregistrement

Certains produits de Boiron ne sont pas enregistrés auprès de la FDA pour un usage humain. Pour les substances non enregistrées (peptides, SARMs sans enregistrement humain), aucun fournisseur légitime à usage humain n'existe. L'absence de filière d'approvisionnement est l'information de sécurité.